Abstract
To identify factors associated with the risk of death in adolescent and adult inpatients with laboratory-positive (reverse-transcription polymerase chain reaction) influenza in Mexico during consecutive influenza seasons (2018-2020). A retrospective cohort study used national surveillance system data, enrolling 3422 individuals. The association between various risk factors and 30-day in-hospital lethality were evaluated through risk ratios (RR) and 95% confidence intervals (CI). The lethality rate was 18.1%. Flu vaccination history (RR = 0.56, 95% CI 0.42-0.78), early antiviral drug administration (≤ two days from symptom onset [reference ≥ 5 days], RR = 0.68, 95% CI 0.58-0.81), and a history of asthma (RR = 0.66, 95% CI 0.47-0.95) showed protective effects against influenza-attributable death. Mechanical ventilator support produced the highest increase in death risk (RR = 3.31, 95% CI 2.89-3.79). Male sex, older age, AH1N1 subtype, and other chronic diseases were also associated with fatal in-hospital influenza-related outcomes. Our findings highlight the major relevance of promoting immunization in high-risk individuals, together with ensuring early and effective antiviral management in suspected influenza cases.
References
Apr 25, 2009·Vaccine·Michael M EndrichThomas D Szucs
Nov 26, 2009·Salud pública de México·Germán E Fajardo-DolciJosé Angel Córdova-Villalobos
Jul 28, 2010·Vaccine·Rodrigo Jiménez-GarcíaPilar Carrasco-Garrido
Oct 16, 2010·PloS One·Hector M Zepeda-LopezLuis M Teran
Jun 2, 2011·PLoS Medicine·Gerardo ChowellVíctor H Borja-Aburto
Jul 14, 2011·PLoS Medicine·Maria D Van KerkhoveUNKNOWN WHO Working Group for Risk Factors for Severe H1N1pdm Infection
Aug 6, 2011·Population Health Metrics·Bernardo HernándezRafael Lozano
Mar 13, 2012·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Luana LenziRoberto Pontarolo
Mar 13, 2012·Thorax·Puja R MylesUNKNOWN Influenza Clinical Information Network (FLU-CIN)
Oct 20, 2012·Archives of Medical Research·Víctor H Borja-AburtoSantiago Echevarría-Zuno
Dec 5, 2013·PLoS Medicine·Lone SimonsenUNKNOWN GLaMOR Collaborating Teams
Apr 25, 2014·BMC Health Services Research·Juan Pablo GutiérrezMauricio Hernández Ávila
Jun 25, 2015·Thorax·Erick FornoJuan C Celedón
May 8, 2016·Journal of Immigrant and Minority Health·Meghan Bridgid MoranSandra Ball-Rokeach
Mar 28, 2017·PloS One·Saverio CainiUNKNOWN Global Influenza B Study group–Latin America
Aug 5, 2017·ClinicoEconomics and Outcomes Research : CEOR·Trung Quang VoArthorn Riewpaiboon
Feb 7, 2018·Bulletin of the World Health Organization·Julia FitznerKatelijn Vandemaele
Mar 6, 2018·Current Epidemiology Reports·Aubree Gordon, Arthur Reingold
May 11, 2018·Human Vaccines & Immunotherapeutics·Ricardo Cortes-AlcalaPablo Kuri-Morales
Jun 8, 2018·PloS One·Chisato ImaiKatharina Merollini
Aug 28, 2018·Frontiers in Immunology·Raja VeerapandianAmali E Samarasinghe
Sep 27, 2018·Annals of Intensive Care·Kuo-Chin KaoUNKNOWN TSIRC (Taiwan Severe Influenza Research Consortium)
Jan 9, 2019·Chest·Sunita MulpuruUNKNOWN Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Jan 12, 2019·PloS One·Ana MartínezUNKNOWN Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working Group
May 8, 2019·Epidemiology and Infection·L Fernandes-MatanoJ E Muñoz-Medina
Jul 22, 2019·Critical Care : the Official Journal of the Critical Care Forum·Andre C Kalil, Paul G Thomas
Jan 25, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Qianda ZouYu Chen
Feb 23, 2020·MMWR. Morbidity and Mortality Weekly Report·Fatimah S DawoodBrendan Flannery
Feb 24, 2020·The Lancet Global Health·Xin WangUNKNOWN Respiratory Virus Global Epidemiology Network